New York-based Priti Radhakrishnan is co-founder and director of Treatment Access at I-MAK (Initiative for Medicines, Access, and Knowledge), which...
New York-based Priti Radhakrishnan is co-founder and director of Treatment Access at I-MAK (Initiative for Medicines, Access, and Knowledge), which uses lawyers and scientists to challenge patents on drugs in poor countries. I-MAK believes that the patent system was designed to balance innovation in medicines and the dissemination of new treatments to society, but the current patent system disproportionately represents and upholds private interests over the public good.
In 2013, I-MAK will focus on bringing down prices for medicine in the developing world; and will take their team—whose work in India paved the way for access to low-cost HIV drugs—to South America and Eastern Europe/Central Asia.
“We're moving to file cases on Hepatitis C drugs because of unconscionable pricing for the 150 million people living with this disease across the world,” Radhakrishnan says.
I-MAK is supported by the technical expertise of pharmaceutical industry scientists, who contribute their talent to help make drugs affordable for low-income communities across the world. A nonprofit, I-MAK is also bolstered by a wide range of donors who contribute to the cause to help make access to medicines a reality for everyone, no matter where they live.
Get this and more delivered to your home by subscribing to GOOD Magazine at subscribe.good.is. It's just $25 for an annual subscription (more than 20% off the cover price)!